Sara Ek

2.6k total citations
75 papers, 1.8k citations indexed

About

Sara Ek is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Sara Ek has authored 75 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pathology and Forensic Medicine, 34 papers in Molecular Biology and 20 papers in Oncology. Recurrent topics in Sara Ek's work include Lymphoma Diagnosis and Treatment (35 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Sara Ek is often cited by papers focused on Lymphoma Diagnosis and Treatment (35 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Sara Ek collaborates with scholars based in Sweden, Denmark and Finland. Sara Ek's co-authors include Carl Borrebaeck, Mats Jerkeman, Michael Dictor, Karin Jirström, Jesper Mørk, Mats Ehinger, Sandra Sernbo, Riikka Räty, Arne Kolstad and Carl‐Magnus Högerkorp and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Sara Ek

73 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Ek Sweden 22 848 656 624 411 235 75 1.8k
Huan‐You Wang United States 24 567 0.7× 761 1.2× 1.2k 1.9× 378 0.9× 39 0.2× 138 2.9k
Ellen C. Obermann Switzerland 26 454 0.5× 1.1k 1.6× 871 1.4× 141 0.3× 266 1.1× 76 2.8k
David Spetzler United States 19 272 0.3× 755 1.2× 616 1.0× 410 1.0× 31 0.1× 84 1.7k
Hongyi Huang United States 17 220 0.3× 1.1k 1.7× 1.6k 2.6× 643 1.6× 62 0.3× 37 2.8k
Jun Ota Japan 19 187 0.2× 406 0.6× 352 0.6× 81 0.2× 71 0.3× 47 1.1k
Kelly Bethel United States 27 205 0.2× 1.2k 1.8× 553 0.9× 258 0.6× 37 0.2× 62 2.3k
André Kajdacsy-Balla United States 17 206 0.2× 184 0.3× 257 0.4× 104 0.3× 109 0.5× 29 1.3k
Ben‐Zion Katz Israel 23 101 0.1× 436 0.7× 1.1k 1.8× 242 0.6× 151 0.6× 62 2.8k
Costas Pitsillides United States 18 122 0.1× 330 0.5× 552 0.9× 165 0.4× 29 0.1× 32 1.8k
Lyndon D. Su United States 19 307 0.4× 598 0.9× 402 0.6× 59 0.1× 19 0.1× 31 1.9k

Countries citing papers authored by Sara Ek

Since Specialization
Citations

This map shows the geographic impact of Sara Ek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Ek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Ek more than expected).

Fields of papers citing papers by Sara Ek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Ek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Ek. The network helps show where Sara Ek may publish in the future.

Co-authorship network of co-authors of Sara Ek

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Ek. A scholar is included among the top collaborators of Sara Ek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Ek. Sara Ek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pyl, Paul Theodor, Anna Sandström Gerdtsson, Urban Gullberg, et al.. (2025). The Progression of Mycosis Fungoides During Treatment with Mogamulizumab: A BIO-MUSE Case Study of the Tumor and Immune Response in Peripheral Blood and Tissue. Biomedicines. 13(1). 186–186.
2.
Olsson, Lina, Paul Theodor Pyl, Louella Vasquez, et al.. (2024). Quantification and Profiling of Early and Late Differentiation Stage T Cells in Mantle Cell Lymphoma Reveals Immunotherapeutic Targets in Subsets of Patients. Cancers. 16(13). 2289–2289. 2 indexed citations
3.
Olsson, Lina, Anna Janská, Darshan Kumar, et al.. (2024). CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression. Blood Advances. 8(16). 4370–4385. 1 indexed citations
4.
Tran, Thi Thu Phuong, Mohamed Jèmaà, Wondossen Sime, et al.. (2024). Enhancing cell death in B-cell malignancies through targeted inhibition of Bcl-3. Cell Death and Disease. 15(9). 690–690. 3 indexed citations
5.
Ek, Sara, et al.. (2024). Empowering macrophages: the cancer fighters within the tumour microenvironment in mantle cell lymphoma. Frontiers in Immunology. 15. 1373269–1373269. 5 indexed citations
6.
Ek, Sara, et al.. (2024). Spatial tumor immune microenvironment phenotypes in ovarian cancer. npj Precision Oncology. 8(1). 148–148. 9 indexed citations
7.
Hollander, Peter, Darshan Kumar, Christian H. Geisler, et al.. (2023). MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and <i>TP53</i>/p53 – a Nordic Lymphoma Group study. Haematologica. 109(4). 1171–1183. 5 indexed citations
8.
Gerdtsson, Anna Sandström, Christian Winther Eskelund, Simon Husby, et al.. (2022). Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established highrisk factors. Haematologica. 108(4). 1092–1104. 2 indexed citations
9.
Hollander, Peter, Caroline E. Weibull, Riikka Räty, et al.. (2021). Infiltration of CD163‐, PD‐L1‐ and FoxP3‐positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors. British Journal of Haematology. 193(3). 520–531. 17 indexed citations
10.
Porwit, Anna, et al.. (2021). Targeted genomic investigations in a population-based cohort of mantle cell lymphoma reveal novel clinically relevant targets. Leukemia & lymphoma. 62(11). 2637–2647. 4 indexed citations
11.
Freiburghaus, C., Christian Winther Eskelund, Christian H. Geisler, et al.. (2020). p53 is associated with high‐risk and pinpointsTP53missense mutations in mantle cell lymphoma. British Journal of Haematology. 191(5). 796–805. 33 indexed citations
12.
Ljungars, Anne, L. Mårtensson, Johanna Sofia Margareta Mattsson, et al.. (2018). A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia. npj Precision Oncology. 2(1). 18–18. 12 indexed citations
13.
Eskelund, Christian Winther, Christina Dahl, Jakob Werner Hansen, et al.. (2017). TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy. Blood. 130(17). 1903–1910. 242 indexed citations
14.
Nordström, Lena, et al.. (2016). SOX11 and HIG-2 are cross-regulated and affect growth in mantle cell lymphoma. Leukemia & lymphoma. 57(8). 1883–1892. 13 indexed citations
15.
Hertwig, Falk, Katharina Meyer, Sebastian Braun, et al.. (2012). Definition of Genetic Events Directing the Development of Distinct Types of Brain Tumors from Postnatal Neural Stem/Progenitor Cells. Cancer Research. 72(13). 3381–3392. 12 indexed citations
16.
Lunnemann, Per, Sara Ek, Kresten Yvind, Rozenn Piron, & Jesper Mørk. (2012). Nonlinear carrier dynamics in a quantum dash optical amplifier. Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU). 6 indexed citations
17.
Conrotto, Paolo, et al.. (2011). Knock‐down of SOX11 induces autotaxin‐dependent increase in proliferation in vitro and more aggressive tumors in vivo. Molecular Oncology. 5(6). 527–537. 29 indexed citations
18.
Sernbo, Sandra, Elin Andersson, Donal J. Brennan, et al.. (2010). SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies. Molecular Cancer. 9(1). 187–187. 59 indexed citations
19.
Ek, Sara, Thomas Drew, Grainne Flannelly, et al.. (2009). SOX11 but not SOX4 is a prognostic marker for improved recurrence free survival in epithelial ovarian cancer. Lund University Publications (Lund University). 116(10). 1407–1407. 3 indexed citations
20.
Ellmark, Peter, Carl‐Magnus Högerkorp, Sara Ek, et al.. (2008). Phenotypic protein profiling of different B cell sub-populations using antibody CD-microarrays. Cancer Letters. 265(1). 98–106. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huan‐You Wang Breakdown of academic impact, for papers by Ellen C. Obermann Breakdown of academic impact, for papers by David Spetzler Breakdown of academic impact, for papers by Hongyi Huang Breakdown of academic impact, for papers by Jun Ota Breakdown of academic impact, for papers by Kelly Bethel Breakdown of academic impact, for papers by André Kajdacsy-Balla Breakdown of academic impact, for papers by Ben‐Zion Katz Breakdown of academic impact, for papers by Costas Pitsillides Breakdown of academic impact, for papers by Lyndon D. Su
Rankless by CCL
2026